These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 21332333

  • 1. Associations of serum levels of advanced glycation end products with nutrition markers and anemia in patients with chronic kidney disease.
    Kratochvilová M, Zakiyanov O, Kalousová M, Kříha V, Zima T, Tesař V.
    Ren Fail; 2011; 33(2):131-7. PubMed ID: 21332333
    [Abstract] [Full Text] [Related]

  • 2. Advanced glycation end-products in patients with chronic alcohol misuse.
    Kalousová M, Zima T, Popov P, Spacek P, Braun M, Soukupová J, Pelinkova K, Kientsch-Engel R.
    Alcohol Alcohol; 2004; 39(4):316-20. PubMed ID: 15208163
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
    Stam F, Schalkwijk CG, van Guldener C, ter Wee PM, Stehouwer CD.
    Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
    [Abstract] [Full Text] [Related]

  • 5. Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease.
    Zakiyanov O, Kalousová M, Kříha V, Zima T, Tesař V.
    Kidney Blood Press Res; 2011 Mar; 34(6):457-64. PubMed ID: 21822023
    [Abstract] [Full Text] [Related]

  • 6. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
    Sebeková K, Somoza V, Jarcusková M, Heidland A, Podracká L.
    Int J Pediatr Obes; 2009 Mar; 4(2):112-8. PubMed ID: 18645732
    [Abstract] [Full Text] [Related]

  • 7. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [Abstract] [Full Text] [Related]

  • 8. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction.
    Mitsnefes M, Kartal J, Khoury P, Daniels S.
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):46-50. PubMed ID: 17699386
    [Abstract] [Full Text] [Related]

  • 9. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
    Sebeková K, Podracká L, Heidland A, Schinzel R.
    Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
    [Abstract] [Full Text] [Related]

  • 10. Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease.
    Busch M, Göbert A, Franke S, Ott U, Gerth J, Müller A, Stein G, Bitsch R, Wolf G.
    Nephron Clin Pract; 2010 Dec; 114(1):c38-46. PubMed ID: 19816042
    [Abstract] [Full Text] [Related]

  • 11. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH.
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G, Collaborative Study Group.
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [Abstract] [Full Text] [Related]

  • 14. Analysis of serum of patients with Alzheimer's disease for the level of advanced glycation end products.
    Leszek J, Malyszczak K, Bartys A, Staniszewska M, Gamian A.
    Am J Alzheimers Dis Other Demen; 2006 Oct; 21(5):360-5. PubMed ID: 17062556
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Advanced glycosylation end products and nutrition--a possible relation with diabetic atherosclerosis and how to prevent it.
    Xanthis A, Hatzitolios A, Koliakos G, Tatola V.
    J Food Sci; 2007 Oct; 72(8):R125-9. PubMed ID: 17995617
    [Abstract] [Full Text] [Related]

  • 18. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ.
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [Abstract] [Full Text] [Related]

  • 19. Advanced glycation end product is implicated in amyloid-related kidney complications.
    Matsunaga N, Anan I, Rosenberg P, Nagai R, Lundström O, Horiuchi S, Ando Y, Suhr OB.
    Scand J Clin Lab Invest; 2005 Dec; 65(4):263-71. PubMed ID: 16076681
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.